Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
Duke University · with Amgen · NCT06471036
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 400
- US sites recruiting
- 1
- Study start
- October 8, 2024
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this implementation trial is to learn if providing education to doctors and patients who have had a heart event works to prevent future heart problems. The main questions it aims to answer are:
- Does educating the doctors in a health system improve how often patients in the hospital for a heart event have their cholesterol checked?
- Can a "care champion" who calls patients who have been discharged from the hospital after a heart event help patients to achieve their cholesterol goals?
Researchers will compare the number of people who achieve their cholesterol goals with the help of the care champion to the number of people who did so without the intervention to see if the care champion works to help patients lower their cholesterol.
Participants will
Complete two 15 minute surveys over the phone - 1 at enrollment and 1 at the end of the study 6 months later.
Being studied: Care Champion Intervention
Conditions: ASCVD; LDL-C
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 18 years old
- Admitted with Type 1 NSTEMI or STEMI, and/or percutaneous coronary revascularization
- LDL-C level during admission ≥ 70 mg/dL
- Primary care clinician and/or cardiologist within the health system (and with access to the same EHR) who will manage the patient in the outpatient setting
Exclusion Criteria
- Determined to be highly unlikely to survive and/or to continue follow-up in that health system for at least 6 months (including those on hospice or with significant dementia), as identified by site investigator
- Underwent CABG (would therefore be discharged from surgical service)
Recruiting US locations
Allina Health
Minneapolis, MN 55407
Site contact: Gretchen Benson · 6128634222 · gbenson@mhif.org
Study contacts (from the official record)
- Neha Pagidipati, MD · 919 668 8742 · neha.pagidipati@duke.edu
Similar studies in Minnesota
All heart & blood pressure studies in Minnesota →- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Rochester, MN + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
- Location
- Rochester, MN + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Minneapolis, MN + 64 other US sites
- Eligibility basics
- Ages 18+